• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about ESALY

    Recent news which mentions ESALY

    < Previous 1 2 3 4 Next >
    Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
    Tickers BIIB ESALY LLY NEWS
    Tags Large Cap Biotech Health Care
    From Benzinga
    Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
    Tickers BIIB ESALY NEWS
    Tags Stories That Matter Briefs News
    From Benzinga
    Europe Just Turned Down Biogen's Alzheimer's Drug. Is the Stock One to Avoid, or a Bad News Buy?
    Tickers BIIB ESALY
    Tags ESALY Market News BIIB
    From Motley Fool
    Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
    Tickers BIIB ESALF ESALY LLY
    Tags Large Cap Biotech Health Care
    From Benzinga
    This Is Massive News for Eli Lilly Investors
    Tickers BIIB ESALY LLY NVO
    Tags Recent Press Releases BIIB ESALY
    From Motley Fool
    Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
    Tickers BIIB ESALY NEWS
    Tags Market News Benzinga Trading Ideas
    From Benzinga
    European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
    Tickers BIIB ESALF ESALY NEWS
    Tags General Movers ESALY
    From Benzinga
    Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
    Tickers BIIB ESALY LLY NEWS
    Tags why it's moving Briefs News
    From Benzinga
    Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
    Tickers BIIB ESALY NEWS NVS
    Tags Market News Analyst Ratings Benzinga
    From Benzinga
    Why Is Biogen Stock Trading Lower On Tuesday?
    Tickers BIIB ESALY NEWS
    Tags Guidance Stories That Matter General
    From Benzinga
    Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
    Tickers BIIB DGX ESALY LH
    Tags LH Benzinga LLY
    From Benzinga
    Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
    Tickers ESALF ESALY MRK
    Tags Large Cap Biotech Health Care
    From Benzinga
    Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
    Tickers ACIU BIIB ESAIY ESALY
    Tags Health Care Biotech Small Cap
    From Benzinga
    Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides
    Tickers BIIB ESALY
    Tags Guidance General Movers
    From Benzinga
    Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
    Tickers BIIB ESALF ESALY LLY
    Tags ESALF General Government
    From Benzinga
    Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
    Tickers BIIB DGX ESALY LH
    Tags General RHHBY News
    From Benzinga
    LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
    Tickers BIIB ESALF ESALY LLY
    Tags Top Stories ESALF General
    From Benzinga
    Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
    Tickers AA AAPL AMZN BIIB
    Tags GOOG GT AMZN
    From Benzinga
    Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
    Tickers BIIB ESALF ESALY
    Tags Benzinga Market News ESALF
    From Benzinga
    Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
    Tickers ESALF ESALY MRK
    Tags General Briefs News
    From Benzinga
    Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
    Tickers ESALF ESALY MRK
    Tags General ESALY News
    From Benzinga
    Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
    Tickers BIIB ESALY RETA
    Tags BIIB Recent Press Releases RETA
    From Motley Fool
    Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
    Tickers BIIB ESALF ESALY
    Tags Analyst Ratings Market News Benzinga
    From Benzinga
    Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
    Tickers BIIB ESALY
    Tags Government BIIB Health Care
    From Benzinga
    FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories
    Tickers AAPL ATVI BEP BIIB
    Tags JTKWY DUK UAL
    From Benzinga
    Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
    Tickers BIIB ESALF ESALY
    Tags General ESALY News
    From Benzinga
    Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
    Tickers BIIB ESALF ESALY
    Tags General Briefs News
    From Benzinga
    Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
    Tickers BIIB ESALY ILMN KDNY
    Tags Futures Benzinga Market News
    From Benzinga
    Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
    Tickers BIIB ESALF ESALY
    Tags Benzinga Market News Alzheimer’s
    From Benzinga
    Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
    Tickers AMZN BLK DIS EADSY
    Tags UBER EADSY NVS
    From Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.